Citations for
1CALM1, CALM2, CALM3, LQT14, LQT15, LQT16
A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.
Limpitikul WB, Dick IE, Tester DJ, Boczek NJ, Limphong P, Yang W, Choi MH, Babich J, DiSilvestre D, Kanter RJ, Tomaselli GF, Ackerman MJ, Yue DT.
Circ Res 120(1):39-48. doi: 10.1161/CIRCRESAHA.116.309283. Epub 2016 Oct 20. 2017
2CALM1, CALM2, CALM3, LQT14, LQT15, LQT16
Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3-specific calmodulinopathy.
Chaix MA, Koopmann TT, Goyette P, Alikashani A, Latour F, Fatah M, Hamilton RM, Rioux JD.
HeartRhythm Case Rep 2(3):250-254. doi: 10.1016/j.hrcr.2016.02.002. eCollection 2016 May. No abstract available. 2016
3CALM1, CALM2, CALM3, LQT14, LQT15, LQT16
Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome-Associated Calmodulin Missense Variant, E141G.
Boczek NJ, Gomez-Hurtado N, Ye D, Calvert ML, Tester DJ, Kryshtal D, Hwang HS, Johnson CN, Chazin WJ, Loporcaro CG, Shah M, Papez AL, Lau YR, Kanter R, Knollmann BC, Ackerman MJ.
Circ Cardiovasc Genet 9(2):136-146. doi: 10.1161/CIRCGENETICS.115.001323. Epub 2016 Mar 11. 2016
4CALM3, LQT16
CALM3 mutation associated with long QT syndrome.
Reed GJ, Boczek NJ, Etheridge SP, Ackerman MJ.
Heart Rhythm 12(2):419-22. doi: 10.1016/j.hrthm.2014.10.035. Epub 2014 Oct 31. No abstract available. 2015